EMORY UNIVERSITY Diversified Active

Location: Atlanta, GA

CIK: 0001377635 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $151M (100.0% shares, 0.0% debt)

Holdings (46)

BRK/A BERKSHIRE HATHAWAY INC DEL 21.9%
Value $33M Shares 117 Est. Cost $230816.08 Unrealized +26.9%
JD JD COM INC 10.3%
Value $15.49M Shares 397,578 Est. Cost $39.72 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 2.4%
Value $3.555M Shares 89,951 Est. Cost $33.70 Unrealized
GENOMIC HEALTH INC 2.4%
Value $3.552M Shares 70,470 Est. Cost $30.22 Unrealized
HRTX HERON THERAPEUTICS INC 2.2%
Value $3.282M Shares 84,475 Est. Cost $31.84 Unrealized 0.0%
SEATTLE GENETICS INC 2.1%
Value $3.103M Shares 46,734 Est. Cost $48.21 Unrealized
ZOGENIX INC 2.0%
Value $3.083M Shares 69,746 Est. Cost $23.79 Unrealized
ABIOMED INC 1.9%
Value $2.89M Shares 7,065 Est. Cost $409.06 Unrealized
TWENTY FIRST CENTY FOX INC 1.9%
Value $2.858M Shares 58,010 Est. Cost $28.15 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 1.9%
Value $2.844M Shares 30,190 Est. Cost $92.48 Unrealized -5.3%
FOLD AMICUS THERAPEUTICS INC 1.9%
Value $2.844M Shares 182,043 Est. Cost $9.97 Unrealized +51.6%
ENDOCYTE INC 1.9%
Value $2.833M Shares 205,295 Est. Cost $13.80 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 1.9%
Value $2.831M Shares 28,819 Est. Cost $55.40 Unrealized +61.6%
MYOVANT SCIENCES LTD 1.9%
Value $2.814M Shares 123,055 Est. Cost $14.64 Unrealized
ALEXION PHARMACEUTICALS INC 1.8%
Value $2.741M Shares 22,081 Est. Cost $134.23 Unrealized
ASND ASCENDIS PHARMA A S 1.8%
Value $2.696M Shares 40,528 Est. Cost $20.24 Unrealized
INCY INCYTE CORP 1.8%
Value $2.669M Shares 39,831 Est. Cost $87.45 Unrealized -21.8%
WVE WAVE LIFE SCIENCES LTD 1.7%
Value $2.598M Shares 67,925 Est. Cost $33.02 Unrealized +30.4%
ALNY ALNYLAM PHARMACEUTICALS INC 1.7%
Value $2.586M Shares 26,256 Est. Cost $87.81 Unrealized +13.0%
TGTX TG THERAPEUTICS INC 1.7%
Value $2.57M Shares 195,463 Est. Cost $13.75 Unrealized 0.0%
IFRX INFLARX NV 1.7%
Value $2.501M Shares 77,554 Est. Cost $26.36 Unrealized +31.0%
KKR & CO L P DEL 1.6%
Value $2.474M Shares 99,559 Est. Cost $21.21 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.6%
Value $2.455M Shares 54,317 Est. Cost $31.71 Unrealized
LA JOLLA PHARMACEUTICAL CO 1.6%
Value $2.426M Shares 83,163 Est. Cost $30.05 Unrealized
BFH ALLIANCE DATA SYSTEMS CORP 1.6%
Value $2.425M Shares 10,400 Est. Cost $153.15 Unrealized -2.2%
SAGE THERAPEUTICS INC 1.6%
Value $2.425M Shares 15,495 Est. Cost $161.05 Unrealized
AWI ARMSTRONG WORLD INDS INC NEW 1.6%
Value $2.343M Shares 37,069 Est. Cost $51.57 Unrealized +7.5%
IOVA IOVANCE BIOTHERAPEUTICS INC 1.5%
Value $2.248M Shares 175,597 Est. Cost $14.62 Unrealized 0.0%
CBRE CBRE GROUP INC 1.5%
Value $2.204M Shares 46,168 Est. Cost $30.58 Unrealized +54.6%
ONC BEIGENE LTD 1.5%
Value $2.202M Shares 14,321 Est. Cost $36.61 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.5%
Value $2.201M Shares 144,125 Est. Cost $25.47 Unrealized -30.0%
CORIUM INTL INC 1.5%
Value $2.2M Shares 274,651 Est. Cost $9.52 Unrealized
DICERNA PHARMACEUTICALS INC 1.5%
Value $2.2M Shares 179,568 Est. Cost $9.56 Unrealized
SLM SLM CORP 1.4%
Value $2.15M Shares 187,754 Est. Cost $11.57 Unrealized 0.0%
KALA PHARMACEUTICALS INC 1.4%
Value $2.12M Shares 154,391 Est. Cost $17.31 Unrealized
SEAGATE TECHNOLOGY PLC 1.4%
Value $2.118M Shares 37,505 Est. Cost $36.82 Unrealized
TRN TRINITY INDS INC 1.4%
Value $2.102M Shares 61,362 Est. Cost $15.77 Unrealized +15.7%
BLUEPRINT MEDICINES CORP 1.4%
Value $2.101M Shares 33,101 Est. Cost $90.89 Unrealized
DBV TECHNOLOGIES S A 1.4%
Value $2.096M Shares 108,679 Est. Cost $27.69 Unrealized
C CITIGROUP INC 1.3%
Value $1.995M Shares 29,811 Est. Cost $53.03 Unrealized 0.0%
MS MORGAN STANLEY 1.2%
Value $1.874M Shares 39,532 Est. Cost $30.43 Unrealized +36.2%
SUMMIT MIDSTREAM PARTNERS LP 0.9%
Value $1.348M Shares 87,560 Est. Cost $25.15 Unrealized
COCRYSTAL PHARMA INC 0.4%
Value $560K Shares 152,916 Est. Cost $5.95 Unrealized
AQUINOX PHARMACEUTICALS INC 0.4%
Value $554K Shares 209,207 Est. Cost $13.15 Unrealized
AMZN AMAZON COM INC 0.2%
Value $269K Shares 158 Est. Cost $71.51 Unrealized +11.0%
SPY SPDR S&P 500 ETF TR 0.2%
Value $237K Shares 872 Est. Cost $266.59 Unrealized